The endothelium-dependent nitric oxide–cGMP pathway

FZ Mónica, K Bian, F Murad - Advances in Pharmacology, 2016 - Elsevier
Abstract Nitric oxide (NO)–cyclic 3′-5′ guanosine monophosphate (cGMP) signaling
plays a critical role on smooth muscle tone, platelet activity, cardiac contractility, renal …

Cerebral small vessel disease: targeting oxidative stress as a novel therapeutic strategy?

TM De Silva, AA Miller - Frontiers in pharmacology, 2016 - frontiersin.org
Cerebral small vessel disease (SVD) is a major contributor to stroke, and a leading cause of
cognitive impairment and dementia. Despite the devastating effects of cerebral SVD, the …

Expression and therapeutic targeting of dopamine receptor-1 (D1R) in breast cancer

DC Borcherding, W Tong, ER Hugo, DF Barnard, S Fox… - Oncogene, 2016 - nature.com
Patients with advanced breast cancer often fail to respond to treatment, creating a need to
develop novel biomarkers and effective therapeutics. Dopamine (DA) is a catecholamine …

Methylene blue: magic bullet for vasoplegia?

L Hosseinian, M Weiner, MA Levin… - Anesthesia & …, 2016 - journals.lww.com
Methylene blue (MB) has received much attention in the perioperative and critical care
literature because of its ability to antagonize the profound vasodilation seen in distributive …

Regulation of soluble guanylyl cyclase redox state by hydrogen sulfide

Z Zhou, E Martin, I Sharina, I Esposito, C Szabo… - Pharmacological …, 2016 - Elsevier
Soluble guanylate cyclase (sGC) is a receptor for nitric oxide (NO). Binding of NO to ferrous
(Fe 2+) heme increases its catalytic activity, leading to the production of cGMP from GTP …

Soluble guanylate cyclase as an alternative target for bronchodilator therapy in asthma

A Ghosh, CJ Koziol-White, K Asosingh… - Proceedings of the …, 2016 - National Acad Sciences
Asthma is defined by airway inflammation and hyperresponsiveness, and contributes to
morbidity and mortality worldwide. Although bronchodilation is a cornerstone of treatment …

[HTML][HTML] Innovative trends and perspectives for erectile dysfunction treatment: A systematic review

EA Ismail, AI El-Sakka - Arab journal of urology, 2016 - Elsevier
Objective To review contemporary knowledge concerning the innovative trends and
perspectives in the treatment of erectile dysfunction (ED). Methods Medline was reviewed for …

[HTML][HTML] The treatment of erectile dysfunction in patients with neurogenic disease

AN Shridharani, WO Brant - Translational Andrology and Urology, 2016 - ncbi.nlm.nih.gov
Erectile dysfunction (ED) related to compromise of the nervous system is an increasingly
common occurrence. This may be due to the multifactorial nature of ED, the myriad of …

Targeting NO/cGMP signaling in the CNS for neurodegeneration and Alzheimer's disease

M Ben Aissa, SH Lee, BM Bennett… - Current medicinal …, 2016 - ingentaconnect.com
cAMP-response element-binding protein (CREB) plays a central role in various aspects of
central nervous system (CNS) function, ranging from the developmental stages to neuronal …

New pharmacological strategies to increase cGMP

A Buglioni, JC Burnett Jr - Annual review of medicine, 2016 - annualreviews.org
The intracellular nucleotide cyclic guanosine monophosphate (cGMP) is found in many
human organ tissues. Its concentration increases in response to the activation of receptor …